SEC Form 4 · accession 0001739452-26-000011
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Xiaobin Wu
Officer — President and COO
Period of report
Aug 25, 2026
Accepted (ET)
Aug 27, 2026 · 5:12 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001651308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| American Depositary SharesF1 | Aug 25, 2026 | S | 280 | $380.00 | D | 0 | D | |
| Ordinary Shares | holding | — | — | — | 1,270,084 | D | ||
| American Depositary SharesF1 | holding | — | — | — | 12,365 | D | ||
| American Depositary SharesF1 | holding | — | — | — | 4,000 | I | By Wife |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Each American Depositary Share represents 13 Ordinary Shares.
- F2The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025.